UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Catalina Capital Group LLC

Catalina Capital Group LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 56.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,755 shares of the healthcare conglomerate’s stock after selling 2,279 shares during the quarter. Catalina Capital Group LLC’s holdings in UnitedHealth Group were worth $919,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.6%

Shares of UNH stock opened at $306.90 on Thursday. The firm has a fifty day moving average of $370.86 and a 200-day moving average of $467.96. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a market capitalization of $278.40 billion, a price-to-earnings ratio of 12.85, a P/E/G ratio of 1.45 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the prior year, the company earned $6.91 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.88%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

Analyst Ratings Changes

A number of research firms have recently commented on UNH. Wolfe Research dropped their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Piper Sandler lowered their price target on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a report on Tuesday, June 3rd. Morgan Stanley lowered their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft lowered their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. Finally, Mizuho lowered their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $426.52.

Insider Activity at UnitedHealth Group

In other news, Director John H. Noseworthy acquired 300 shares of the firm’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the business’s stock in a transaction dated Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.